Quotient Sciences has acquired Arcinova, a U.K.-based CDMO. Arcinova has 160 employees, and provides drug substance, drug product and bioanalysis services to more than 200 pharma/biopharma customers worldwide.
Arcinova has invested in a Uniqsis FlowSyn continuous flow reactor enabling them to develop and simplify the scale-up of a challenging API batch process.